JUNS Jupiter Neurosciences
- 6.000
- 0.0000.00%
Jupiter Neurosciences News
Jupiter Neurosciences, Inc. Announces Research Breakthrough With JOTROL™ in Parkinson's Disease
JUPITER, Fla. and BOSTON, Feb. 27, 2023 /PRNewswire/ -- Jupiter Neurosciences, Inc. ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company advancing a pipeline focused on the treatment of
Jupiter Neurosciences, Inc. Announces Appointment of New Chief Financial Officer
JUPITER, Fla. and BOSTON, Jan. 12, 2023 /PRNewswire/ -- Jupiter Neurosciences, Inc. ("JUPITER" or the "Company"), a clinical-stage pharmaceutical company advancing a pipeline focused on the treatment of
Jupiter Neurosciences Expects to Offer 2.6M Shrs in IPO; For Purposes of Prospectus, Assumed Price Is $5.75 Each
Jupiter Neurosciences Expects to Offer 2.6M Shrs in IPO; For Purposes of Prospectus, Assumed Price Is $5.75 Each
US stock IPO forecast for this week: 5 IPOs to be listed, 2 are likely
This week's IPOs include 2 Chinese securities — Ricon China (LICN) and Material Core Technology (WXT).
Jupiter Neurosciences, Inc. Prices IPO at $5.00-$7.00 Per Share (JUNS)
Jupiter Neurosciences, Inc. (JUNS) is planning to raise $15 million in an IPO on Wednesday, September 21st, IPO Scoop reports. The company plans to issue 2,500,000 shares at $5.00-$7.00 per share. S
Catalyst Watch: Eyes On Nvidia, Salesforce, Rocket Lab, Rumble and Qualcomm
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events
Jupiter Neurosciences, Inc IPOs Tomorrow, Here's What You Need To Know
Jupiter Neurosciences, Inc (NASDAQ:JUNS) IPO will take place September, 14 on the NASDAQ exchange under the ticker JUNS. The company is offering shares at an expected price between $5.00 and $7.00 pe
US stock IPO forecast for this week: 6 new companies to go public, focus on Corebridge's performance
CoreBridge, previously known as SAFG Insurance Services, Inc., is AIG's retirement service and life insurance business.
This Week's Scheduled IPOs
With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these enticing companies are s
Jupiter Neurosciences, Inc. (JUNS) to Raise $15 Million in IPO
Jupiter Neurosciences, Inc. (JUNS) is planning to raise $15 million in an initial public offering on the week of September 12th, IPO Scoop reports. The company will issue 2,500,000 shares at a price
IPO Previews For The Week
With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these enticing companies are s
Jupiter Neurosciences Inc Plans $15 Million IPO for September 7th (JUNS)
Jupiter Neurosciences Inc (JUNS) is planning to raise $15 million in an IPO on Wednesday, September 7th, IPO Scoop reports. The company plans to issue 2,500,000 shares at $5.00-$7.00 per share. Jupi
Jupiter Neurosciences Expects to Offer 2.5M Shrs in IPO at Price Between $5 and $7 Each; Previously Planned to Offer 2.2M Units Containing Stock and Warrants at $6-$8 Each
Jupiter Neurosciences Expects to Offer 2.5M Shrs in IPO at Price Between $5 and $7 Each; Previously Planned to Offer 2.2M Units Containing Stock and Warrants at $6-$8 Each
BRIEF-Jupiter Neurosciences Inc Announces Journal Of Alzheimer's Disease Publication Highlighting Use Of Jotrol
June 14 (Reuters) - Jupiter Neurosciences Inc JUNS.O :* JUPITER NEUROSCIENCES, INC. ANNOUNCES JOURNAL OF ALZHEIMER'S DISEASE PUBLICATION HIGHLIGHTING USE OF JOTROL™Source text for Eikon: ID:nPn92XDt
Jupiter Neurosciences, Inc. Announces Completion of Phase I Safety Trial with Enhanced Resveratrol Product, JOTROL™
JUPITER, Fla. and BOSTON, Feb. 23, 2022 /PRNewswire/ -- Jupiter Neurosciences, Inc. ("Jupiter" or the "Company"), today announced the completion of its Phase I clinical trial with its proprietary JOTROL™, an enhanced formulation of resveratrol wit
Jupiter Neurosciences to Issue 2.2 Million Units in IPO
04:10 AM EST, 01/27/2022 (MT Newswires) -- Jupiter Neurosciences said Wednesday it is planning to sell 2.2 million units with an expected price of between $6 and $8 per unit. Each unit consists of o
Jupiter Neurosciences aims to raise up to $20.24M in IPO
Jupiter Neurosciences (NASDAQ:JUNS) has set terms for an initial public offering of its stock, aiming to raise up to $20.24M from the deal. The biotech company said in a filing that it intends to of
BRIEF-Jupiter Neurosciences Inc Now Sees IPO Of Up To 2.2 Million Units Priced To Be Between $6.00 And $8.00 Per Unit - SEC Filing
Jan 26 (Reuters) - Jupiter Neurosciences Inc JUNS.O :* JUPITER NEUROSCIENCES INC NOW SEES IPO OF UP TO 2.2 MILLION UNITS PRICED TO BE BETWEEN $6.00 AND $8.00 PER UNIT - SEC FILING* JUPITER NEUROSCIEN
US stock IPO forecast for this week: a total of 7 companies will go public on IPOs
A total of 7 companies are about to go public with IPOs this week, all of which are small capitalization companies.
Jupiter Neurosciences Files for Initial Public Offering
By Colin Kellaher Jupiter Neurosciences Inc. on Tuesday filed with the U.S. Securities and Exchange Commission for an initial public offering. The filing by the Jupiter, Fla., clinical-st
Analysis
Price Target
No Data
